Loading...
Valsartan
India Pharmaceutical Trade Intelligence
Who Supplies Valsartan to India from SPAIN
India's valsartan imports from SPAIN total $243.5K across 19 shipments from 6 foreign suppliers. NOVARTIS PHARMA AG leads with $173.7K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include NOVARTIS INDIA LIMITED. This corridor reflects India's pharmaceutical import demand for valsartan — a diversified sourcing base with multiple active suppliers from SPAIN.
Top foreign suppliers (SPAIN) — Ranked by import value
NOVARTIS PHARMA AG is the leading Valsartan supplier from SPAIN to India, with import value of $173.7K across 10 shipments. The top 5 suppliers — NOVARTIS PHARMA AG, M/S. NOVARTIS PHARMA AG, Novartis Pharma AG, ESPEE BIOPHARMA & FINECHEM LLC, LABORATORIOS LICONSA S.A. — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (SPAIN)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NOVARTIS PHARMA AG | $173.7K | 10 | 71.4% |
| 2 | M/S. NOVARTIS PHARMA AG | $44.1K | 2 | 18.1% |
| 3 | Novartis Pharma AG | $21.9K | 1 | 9.0% |
| 4 | ESPEE BIOPHARMA & FINECHEM LLC | $3.4K | 1 | 1.4% |
| 5 | LABORATORIOS LICONSA S.A. | $387 | 2 | 0.2% |
| 6 | M/S LABORATORIOS UNIVERSAL FARMA, S.L. | $4 | 3 | 0.0% |
Showing top 6 of 6 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from SPAIN)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NOVARTIS INDIA LIMITED | $239.7K | 13 | 98.5% |
| 2 | AJANTA PHARMA LIMITED | $3.4K | 1 | 1.4% |
| 3 | CLIANTHA RESEARCH LIMITED | $387 | 2 | 0.2% |
| 4 | CHEMO INDIA FORMULATION PRIVATE LIMITED | $4 | 3 | 0.0% |
Import Statistics
- Import Value
- $243.5K
- Shipments
- 19
- Foreign Suppliers
- 6
- Indian Buyers
- 4
- Avg. Shipment
- $12.8K
Other Valsartan Import Origins
Frequently Asked Questions — Valsartan Imports from SPAIN
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Valsartan suppliers from SPAIN to India?
The top Valsartan suppliers from SPAIN to India include NOVARTIS PHARMA AG, M/S. NOVARTIS PHARMA AG, Novartis Pharma AG. The leading supplier is NOVARTIS PHARMA AG with import value of $173.7K USD across 10 shipments. India imported Valsartan worth $243.5K USD from SPAIN in total across 19 shipments.
QHow much Valsartan does India import from SPAIN?
India imported Valsartan worth $243.5K USD from SPAIN across 19 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Valsartan from SPAIN?
The main Indian buyers of Valsartan sourced from SPAIN include NOVARTIS INDIA LIMITED, AJANTA PHARMA LIMITED, CLIANTHA RESEARCH LIMITED. The largest buyer is NOVARTIS INDIA LIMITED with $239.7K in imports across 13 shipments.
QWhat is the total value of Valsartan imports from SPAIN to India?
The total value of Valsartan imports from SPAIN to India is $243.5K USD, across 19 shipments and 6 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: SPAIN to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Valsartan.
- 2.Supplier/Buyer Matching: 6 foreign suppliers from SPAIN and 4 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $243.5K aggregated from 19 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
19 Verified Shipments
6 suppliers, 4 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists